Takeda Pharmaceutical (TKPHF) Non-Current Assets (2017 - 2026)

Takeda Pharmaceutical's Non-Current Assets history runs 10 years deep, the most recent figure standing at $78.8 billion for Q1 2026.

• In Q1 2026, Non-Current Assets rose 2.55% year-over-year to $78.8 billion; the TTM figure through Mar 2026 stood at $78.8 billion (up 2.55% YoY), while the FY2026 annual figure was $82.1 billion, up 6.68% from the prior year.
• Non-Current Assets was $78.8 billion for Q1 2026 at Takeda Pharmaceutical, down from $79.9 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $91.1 billion in Q1 2022 to a low of $76.9 billion in Q1 2025.
• Historically, Non-Current Assets has averaged $82.8 billion across 5 years, with a median of $81.3 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Non-Current Assets dropped 14.12% in 2022, then climbed 3.33% in 2023.
• A 5-year view of Non-Current Assets shows it stood at $77.2 billion in 2022, then advanced by 3.33% to $79.8 billion in 2023, then increased by 1.83% to $81.3 billion in 2024, then fell by 1.7% to $79.9 billion in 2025, then retreated by 1.31% to $78.8 billion in 2026.
• The last three Non-Current Assets figures came in at $78.8 billion (Q1 2026), $79.9 billion (Q4 2025), and $78.4 billion (Q3 2025), per Business Quant data.